PHLDA2 and nonpapillary renal cell carcinoma: Moreover, various immune-related pathways, in which both positive and negative regulations of the immune system were observed, were up-regulated as well, reflecting the complicated nature of the TME in PHLDA2-H subgroup of ccRCC (Fig. 4G).